Figure 3
Figure 3. CFHR1 regulates C5 convertase activity, binds to C5 and C5b6, and inhibits binding of C5b6 to the cell surfaces. (A) Sheep erythrocytes were incubated in complement active CFH/CFHR1-depleted HP (HPΔCFH) in the presence or absence of CFHR1 (18-300 μg/mL). Lysis was recorded after 30 minutes. In addition, the concentration of C3a (gray squares) and C5a (red triangles) was assayed in the supernatant. Data represent mean values of 3 separate experiments and SDs are indicated. *P < .05, **P < .005 versus control. (B) Effect of CFHR1 on C3b (solid line) and C5/C5b (stippled line) deposition on the surface of sheep erythrocytes. Sheep erythrocytes were incubated in HPΔCFH-ΔC8 plasma, and deposition of C3b and C5b was assayed in the presence of increasing concentrations of CFHR1 (10, 20, and 40 μg/mL, red solid and stippled lines) and CFH (10, 20, and 40 μg/mL, blue solid and stippled lines) by flow cytometry. Data represent mean values ± SDs of 3 separate experiments. (C) CFHR1 inhibits C5/C5b deposition on sheep erythrocytes (v) that were incubated in human CFH- and C8-depleted plasma (HPΔCFH-ΔC8). CFHR1 does not effect C3b deposition (ii). Factor H (CFH) inhibits both C3b and C5/C5b deposition (iii and vi). Bars represent 10 μm. (D) CFHR1 inhibits C5 convertase activity. Recombinant CFHR1 (column 3) as well as plasma-purified CFHR1 (column 4) inhibit the C5 convertase and cleavage of C5. The C5 convertase was generated on the surface of sheep erythrocytes using purified C3, factor B, and factor D in the presence of Ni2+ and properdin. Cleavage and C5a generation was determined by ELISA. CFH also affected C5a generation (column 5) in contrast to BSA (column 6). Data represent mean values of 3 separate experiments and SDs are indicated. *P < .05, **P < .005 versus BSA.

CFHR1 regulates C5 convertase activity, binds to C5 and C5b6, and inhibits binding of C5b6 to the cell surfaces. (A) Sheep erythrocytes were incubated in complement active CFH/CFHR1-depleted HP (HPΔCFH) in the presence or absence of CFHR1 (18-300 μg/mL). Lysis was recorded after 30 minutes. In addition, the concentration of C3a (gray squares) and C5a (red triangles) was assayed in the supernatant. Data represent mean values of 3 separate experiments and SDs are indicated. *P < .05, **P < .005 versus control. (B) Effect of CFHR1 on C3b (solid line) and C5/C5b (stippled line) deposition on the surface of sheep erythrocytes. Sheep erythrocytes were incubated in HPΔCFH-ΔC8 plasma, and deposition of C3b and C5b was assayed in the presence of increasing concentrations of CFHR1 (10, 20, and 40 μg/mL, red solid and stippled lines) and CFH (10, 20, and 40 μg/mL, blue solid and stippled lines) by flow cytometry. Data represent mean values ± SDs of 3 separate experiments. (C) CFHR1 inhibits C5/C5b deposition on sheep erythrocytes (v) that were incubated in human CFH- and C8-depleted plasma (HPΔCFH-ΔC8). CFHR1 does not effect C3b deposition (ii). Factor H (CFH) inhibits both C3b and C5/C5b deposition (iii and vi). Bars represent 10 μm. (D) CFHR1 inhibits C5 convertase activity. Recombinant CFHR1 (column 3) as well as plasma-purified CFHR1 (column 4) inhibit the C5 convertase and cleavage of C5. The C5 convertase was generated on the surface of sheep erythrocytes using purified C3, factor B, and factor D in the presence of Ni2+ and properdin. Cleavage and C5a generation was determined by ELISA. CFH also affected C5a generation (column 5) in contrast to BSA (column 6). Data represent mean values of 3 separate experiments and SDs are indicated. *P < .05, **P < .005 versus BSA.

Close Modal

or Create an Account

Close Modal
Close Modal